Published in

Karger Publishers, CardioRenal Medicine, 1(10), p. 22-31, 2019

DOI: 10.1159/000502254

Links

Tools

Export citation

Search in Google Scholar

Changes in Estimated Glomerular Filtration after Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

<b><i>Background:</i></b> Balloon pulmonary angioplasty (BPA) is a novel treatment option for inoperable or persistent chronic thromboembolic pulmonary hypertension (CTEPH). Little is known about renal function in CTEPH patients undergoing BPA. <b><i>Objectives:</i></b> The aim of this study was to assess the frequency of contrast-induced acute kidney injury (CI-AKI) in patients with CTEPH undergoing BPA and to evaluate the relationship between hemodynamic and renal function. <b><i>Methods:</i></b> A total of 41 CTEPH patients were included and 250 consecutive BPA sessions were analyzed for frequency of CI-AKI. The serum creatinine (SC) concentration was measured and the glomerular filtration rate (GFR) was estimated using the Modification of Diet in Renal Disease equation before and 72 h after each BPA procedure. CI-AKI was defined as an increase of 25% or 0.5 mg/dL in SC from the baseline value within 48–72 h of contrast administration. SC and GFR were assessed before and after 3–6 months of completing the BPA treatment and correlated with hemodynamic parameters. <b><i>Results:</i></b> The SC concentration and GFR did not change significantly within 72 h after BPA (+1%, <i>p</i> = 0.921, and +4%, <i>p</i> = 0.112, respectively). CI-AKI was noted in 2 cases (0.8%). Significant improvement was noted in GFR (75.4 ± 21.2 vs. 80.9 ± 22.4 mL/min/1.73 m<sup>2</sup>; <i>p</i> = 0.012) in addition to improvement in right atrial pressure (RAP; 9.1 ± 4.1 to 5.0 ± 2.2 mm Hg; <i>p</i> &#x3c; 0.001), mean pulmonary artery pressure (49.1 ± 10.7 to 29.8 ± 8.3 mm Hg; <i>p</i> &#x3c; 0.001), cardiac index (CI; 2.42 ± 0.6 to 2.70 ± 0.6 L/min/m<sup>2</sup>; <i>p</i> = 0.004), and pulmonary vascular resistance (9.42 ± 3.6 to 4.4 ± 2.3 Wood units; <i>p</i> &#x3c; 0.001). In a subpopulation of 12 patients with impaired renal function at baseline, the relative increase in GFR was significantly correlated with relative improvement in CI (<i>r</i> = 0.060; <i>p</i> = 0.037), RAP (<i>r</i> = –0.587; <i>p</i> = 0.044), and mixed venous saturation (<i>r</i> = 0.069; <i>p</i> = 0.012). <b><i>Conclusions:</i></b> Hemodynamically effective BPA procedures improve renal function in patients with CTEPH with a minimal risk of CI-AKI in the course of treatment.